Chemical Compound

Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propen-1-yl)-, (5a)-; Morphinan-6-one, 17-allyl-4,5a-epoxy-3,14-dihydroxy- (8CI); Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5a)- (9CI); Normorphinone, N-allyl-7,8-dihydro-14-hydroxy- (7CI); (-)-Naloxone; 12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro[4,5-bcd]furan-5(6H)-one; NSC 70413; Naloxone; l-Naloxone

CAS Registry Number 465-65-6
返回搜索 申请报价
Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propen-1-yl)-, (5a)-; Morphinan-6-one, 17-allyl-4,5a-epoxy-3,14-dihydroxy- (8CI); Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5a)- (9CI); Normorphinone, N-allyl-7,8-dihydro-14-hydroxy- (7CI); (-)-Naloxone; 12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro[4,5-bcd]furan-5(6H)-one; NSC 70413; Naloxone; l-Naloxone 结构式
Primary record

Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propen-1-yl)-, (5a)-; Morphinan-6-one, 17-allyl-4,5a-epoxy-3,14-dihydroxy- (8CI); Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5a)- (9CI); Normorphinone, N-allyl-7,8-dihydro-14-hydroxy- (7CI); (-)-Naloxone; 12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro[4,5-bcd]furan-5(6H)-one; NSC 70413; Naloxone; l-Naloxone

库存
1,101 克
纯度
98.3 %
CAS
465-65-6

化合物标识与属性

CAS
465-65-6
PubChem CID
5284596
SMILES
C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O
Canonical SMILES
C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5

名称与同义词

  • naloxone
  • l-Naloxone
  • Narcan
  • Naloxona
  • Naloxonum
  • (-)-Naloxone
  • n-Allylnoroxymorphone
  • Nalossone
  • Narcanti
  • Nalone
  • Narcon
  • Nalossone [DCIT]
  • DBL Naloxone
  • Naloxone HCl
  • EN 1530 base
  • N-Allyl-noroxymorphone
  • Naloxonum [INN-Latin]
  • Nyxoid
  • Naloxona [INN-Spanish]
  • Evzio
  • [3H]naloxone
  • Naloxone Nasal Spray
  • Naloxone [INN:BAN]
  • Naloxone (INN)
  • 465-65-6
  • Abello, Naloxone
  • Curamed, Naloxon
  • Naloxon ratiopharm
  • Naloxone hydrochloride
  • Narcanti (TN)
  • Nalone (TN)
  • Narcan (TN)
  • Naloxone Hydrobromide
  • SUBOXONE
  • naloxoni hydrochloridum
  • DBL Naloxone (TN)
  • Hydrobromide, Naloxone
  • RefChem:6051
  • A1APV
  • NALOXONE [HSDB]
  • EN 1530base
  • NALOXONE [INN]
  • 1-N-Allyl-14-hydroxynordihydromorphinone
  • NALOXONE [MI]
  • CHEMBL80
  • HSDB 3279
  • NALOXONE [VANDF]
  • Prestwick0_000111
  • Prestwick1_000111
  • Prestwick2_000111
  • Prestwick3_000111
  • 36B82AMQ7N
  • CHEBI:7459
  • UNII-36B82AMQ7N
  • DTXSID8023349
  • [N-allyl-2,3-3H]naloxone
  • D0RN5A
  • D0X3FX
  • Epitope ID:549277
  • NALOXONE [USP-RS]
  • NALOXONE [WHO-DD]
  • DTXCID703349
  • NALOXONE [EMA EPAR]
  • NSC-70413
  • SCHEMBL34284
  • BSPBio_000122
  • MRZ 2593Br
  • naloxone hydrochloride hydrate
  • NIOSH/QD2135000
  • C19H21NO4
  • l-N-Allyl-14-hydroxynordihydromorphinone
  • MLS000069540
  • MLS000736771
  • BIDD:GT0110
  • EINECS 207-365-7
  • RAM-301
  • SPBio_002061
  • MRZ 2593 Br
  • MRZ 2593-Br
  • NALOXONE [ORANGE BOOK]
  • NSC 70413
  • UZHSEJADLWPNLE-GRGSLBFTSA-N
  • BPBio1_000136
  • GTPL1638
  • GTPL1676
  • Naloxone hydrochloride dihydrate
  • SCHEMBL29427581
  • 1-N-Allyl-7,8-dihydro-14-hydroxynormorphinone
  • BDBM54795
  • cid_5464092
  • A06AH04
  • BRN 1089071
  • Dihydride, Naloxone Hydrochloride
  • Hydrochloride Dihydride, Naloxone
  • MRZ2593
  • V03AB15
  • BDBM579486
  • HMS2090F20
  • l-N-Allyl-7,8-dihydro-14-hydroxynormorphinone
  • ZINC389747
  • 17-Allyl-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one
  • MRZ 2593
  • NSC70413
  • US11484525, Compound Naloxone
  • Tox21_112006
  • BDBM50000788
  • C19-H21-N-O4
  • EBC-26597
  • HY-17417A
  • PDSP2_001520
  • 17-Allyl-4,5-alpha-epoxy-3,14-dihydroxymorphinan-6-one
  • AKOS016009988
  • Tox21_112006_1
  • CID5284596
  • DB01183
  • FN61467
  • J5.894G
  • N-Allyl-4,5alpha-epoxy-3,14-dihydroxy-6-morphinanon
  • SMP1_000205
  • 7,8-Dihydro-N-allyl-14-hydroxynormorphinone
  • NCGC00024674-02
  • NCGC00024674-03
  • NCGC00024674-14
  • NCGC00162267-02
  • NCGC00274058-01
  • QD21350000
  • AJ-20933
  • AN-45114
  • Analog of 14-(Arylhydroxyamino)codeinone
  • CAS-465-65-6
  • DA-65917
  • LS-92141
  • O940
  • SMR000058766
  • 17-allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one
  • Morphinan-6-one, 17-allyl-4,5alpha-epoxy-3,14-dihydroxy-
  • Normorphinone, N-allyl-7,8-dihydro-14-hydroxy-, (-)-
  • LS-187184
  • Normorphinone, N-allyl-dihydro-14-hydroxy-
  • 4683B
  • CS-0012343
  • Kloxxado (naloxone hydrochloride nasal spray)
  • Normorphinone, 7,8-dihydro-N-allyl-14-hydroxy-
  • NS00002914
  • (-)-N-allyl-14-hydroxynordihydroxymorphinan-6-one
  • Morphinan-6-one, 4,5alpha-epoxy-3,14-dihydroxy-17-(2-propenyl)-
  • 12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro(4,5-bcd)furanone
  • C07252
  • D08249
  • H55415
  • Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5alpha)-
  • 465N656
  • EN300-19748912
  • Morphinan-6-one,5.alpha.-epoxy-3,14-dihydroxy-
  • Q282902
  • (-)-N-ALLYL-14-HYDROXYNORDIHYDROMORPHINONE
  • 17-Allyl-3,14-dihydroxy-4,5-alpha-epoxymorphinan-6-one
  • (5alpha)-4,5-Epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one
  • BRD-K67511046-001-02-3
  • BRD-K67511046-003-03-7
  • BRD-K67511046-003-14-4
  • BRD-K67511046-003-15-1
  • BRD-K67511046-003-16-9
  • Morphinan-6-one, 17-allyl-3,14-dihydroxy-4,5-alpha-epoxy-
  • Morphinan-6-one, 4,5-alpha-epoxy-3,14-dihydroxy-17-(2-propenyl)-
  • (4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one
  • 4,5alpha-Epoxy-17-allyl-3,14-dihydroxymorphinan-6-one
  • 3,14-dihydroxy-17-(prop-2-en-1-yl)-4,5alpha-epoxymorphinan-6-one
  • (1S,5R,13R,17S)-10,17-dihydroxy-4-(prop-2-en-1-yl)-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one
  • (5alpha)-3,14-dihydroxy-17-prop-2-en-1-yl-4,5-epoxymorphinan-6-one
  • 17-ALLYL-4,5A-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE
  • (5?)-3,14-Dihydroxy-17-prop-2-en-1-yl-4,5-epoxymorphinan-6-one
  • Morphinan-6-one, 17-allyl-4,5alpha-epoxy-3,14-dihydroxy- (8CI)
  • Morphinan-6-one, 17-allyl-4,5alpha-epoxy-3,14-dihydroxy-(8CI)
  • Morphinan-6-one,5.alpha.-epoxy-3,14-dihydroxy-17-(2-propenyl)-
  • (5-alpha)-4,5-Epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one
  • (5alpha)-4,5-Epoxy-3,14-dihydroxy-17-(2-propen-1-yl)morphinan-6-one
  • [17-(2,3-3H-2-propenyl)]-4, 5a -epoxy-3,14-dihydroxymorphinan-6-one
  • 12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro[4,5-bcd]furan-5(6H)-one
  • 3,14-Dihydroxy-17-(prop-2-en-1-yl)-5alpha-4,5-epoxymorphinan-6-one
  • MORPHINAN-6-ONE, 4,5-EPOXY-3,14-DIHYDROXY-17-(2-PROPENYL)-
  • Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-,(5.alpha.)-
  • Morphinan-6-one,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5.alpha.)-
  • 2-(([2-(ETHYLTHIO)-3-PYRIDYL]CARBONYL)AMINO)-4-(METHYLTHIO)BUTANOICACID
  • 4aH-8,5-bcd]furan-5(6H)-one, N-allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-
  • Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5.alpha.)-
  • Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5alpha)- (9CI)
  • Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5alpha)-(9CI)
  • Naloxone solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
  • (1S,5R,13R,17S)-10,17-dihydroxy-4-(prop-2-en-1-yl)-12-oxa-4-azapentacyclo(9.6.1.0^(1,13).0^(5,17).0^(7,18))octadeca-7(18),8,10-trien-14-one
  • (1S,5R,13R,17S)-10,17-dihydroxy-4-(prop-2-en-1-yl)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7,9,11(18)-trien-14-one
  • (4R)-6,10abeta-Dihydroxy-11-allyl-4alpha,5-epoxy-10beta,4abeta-(epiminoethano)-1,2,3,4,4a,9,10,10a-octahydrophenanthren-3-one
  • (4R,4aS,7aR,12bS)-3-allyl-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
  • (4R,4aS,7aR,12bS)-4a,9-bis(oxidanyl)-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
  • (4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro(3,2-e)isoquinolin-7-one
  • (4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro(3,2-e)isoquinoline-7-one
  • (4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
  • (4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
  • (Morphine)4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol
  • (naloxone) 4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one
  • (naloxone)4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one
  • (naloxone)4-allyl-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one
  • 207-365-7
  • 4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one
  • 4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one (naloxone)
  • 4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one( Naloxone)
  • 4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one(Naxolone)
  • 4-allyl-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one
  • 4-allyl-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one(naloxone)C2H2O4
  • Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propen-1-yl)-, (5a)-; Morphinan-6-one, 17-allyl-4,5a-epoxy-3,14-dihydroxy- (8CI); Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5a)- (9CI); Normorphinone, N-allyl-7,8-dihydro-14-hydroxy- (7CI); (-)-Naloxone; 12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro[4,5-bcd]furan-5(6H)-one; NSC 70413; Naloxone; l-Naloxone